Financials

  • Market Capitalization 10.68 B
  • Employee 69
  • Founded 2013
  • CEO Marc de GaridelHartmut J. Ehrlich
  • Website www.abivax.com
  • Headquarter France
  • FIGI BBG01JLQNZ03
  • Industry Biotechnology

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
858
TECH
Bio-Techne Corp - Common Stock
71.36 USD+0.08%+0.62%+29.02%+34.67%11.17 B USD
878
KRYS
Krystal Biotech, Inc. - Common Stock
363.44 USD-0.65%-3.21%+14.29%+94.22%10.71 B USD
893
ARWR
Arrowhead Pharmaceuticals, Inc. - Common Stock
74.11 USD-3.00%-14.62%-0.59%+89.54%10.44 B USD
906
CYTK
Cytokinetics, Incorporated - Common Stock
82.24 USD-3.10%-4.47%+17.23%+41.55%10.23 B USD

Frequently asked questions about Abivax SA - American Depositary Shares

What is the Abivax SA - American Depositary Shares stock price today?

The current price of Abivax SA - American Depositary Shares (ABVX) is 135.98. Over the past 24 hours, the stock has changed by -2.80%. Follow the ABVX chart for real-time price dynamics.

What is the stock ticker of Abivax SA - American Depositary Shares?

Abivax SA - American Depositary Shares trades under the ticker ABVX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Abivax SA - American Depositary Shares stock going up?

ABVX has changed by -4.58% over the last week, +36.53% over the last month, and +1410.89% over the last year. Review the chart to see whether the current move is part of a broader trend.

How many employees does Abivax SA - American Depositary Shares have?

As of the latest available data, Abivax SA - American Depositary Shares has 69 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Abivax SA - American Depositary Shares stock?

You can buy Abivax SA - American Depositary Shares (ABVX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Abivax SA - American Depositary Shares stock?

Investing in Abivax SA - American Depositary Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ABVX chart and related analysis on metatrader.com as part of your research.

Abivax SA - American Depositary Shares

Abivax SA is a clinical stage biotechnology company focused on developing innovative treatments that harness the body’s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases. Abivax has a program in clinical development with its lead drug candidate, obefazimod, to treat ulcerative colitis. Another program in Crohn’s disease is also in preparation and other potential inflammatory indications are being evaluated. The company’s headquarters are based in Paris, France with a US office in Waltham, Massachusetts. Abivax’s Research and development work is conducted at its research center based in Montpellier, France.

News